Reported Reactions

Devices › Pulse generator, permanent, implantable

Device brand name · Pulse generator permanent implantable

Azure: medical device reports filed with FDA

919 reports name it, 2018–2019. Manufacturer given most often on reports: Medtronic Puerto Rico Operations. Product code NVZ.

919
device reports naming the brand
0% of all MAUDE reports · about 109 a year
0
reports, 12 months to August 2026
0 in the 12 months before
43.2%
classified as malfunction
43.5% across the product code
1.8%
classified as death, as reported
17 reports · not verified by FDA

919 medical device reports received by FDA name the brand "Azure" (pulse generator permanent implantable); the manufacturer given most often on reports is Medtronic Puerto Rico Operations; received from February 2018 to May 2019. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (55%), malfunction (43.2%) and death (1.8%); across all pulse generator, permanent, implantable reports (product code NVZ) death is recorded in 4.1% and malfunction in 43.5%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are incorrect measurement (13.1%), mechanical problem (11.1%) and pacing problem (9.6%). The patient problems coded most often are hematoma, erosion and bradycardia. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Azure was received in the five years to August 2026; the latest was received in May 2019.

Event type and report source

Event type, as classified on the report

Death1.8%17
Injury55%505
Malfunction43.2%397
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%919
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 95,612 reports carrying product code NVZ. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Incorrect measurementthe device measured wrongly12013.1%1.6%
Mechanical problema mechanical problem10211.1%3.9%
Pacing problem889.6%10.5%
Unable to obtain readings778.4%1.9%
Over-sensing232.5%5.6%
Reset problem232.5%1.4%
False alarm222.4%1.1%
Inappropriate or unexpected reset212.3%1.9%
High impedance192.1%1.7%
Protective measures problem192.1%0.3%
Failure to capture171.8%3.4%
Migration or expulsion of device171.8%1.1%
Low impedance151.6%0.7%
Data problem141.5%0.8%
Impedance problem141.5%0.5%
Device sensing problem131.4%1.4%
Output problem121.3%0.6%
Electromagnetic interference111.2%0.9%
High capture threshold101.1%0.5%
Insufficient device problem information91%1.8%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Hematomaa collection of blood under the skin or in tissue252.7%
Erosion242.6%
Bradycardiaslow heart rate171.8%
Deaththe patient died; cause not stated by this term171.8%
Syncopefainting171.8%
Dizzinesslight-headedness or unsteadiness151.6%
No patient involvement151.6%
Complaint, ill-defined141.5%
Dyspneashortness of breath141.5%
Painpain, site not specified111.2%
Pocket erosion111.2%
Sepsisa severe body-wide response to infection101.1%
Weakness80.9%
Palpitationsawareness of the heartbeat70.8%
Atrial fibrillationan irregular heart rhythm60.7%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureAzureProduct code NVZAll MAUDE reports
Reports91995,61226,136,888
Share of that pool—1%0%
Classified as death, per 1,000 reports18419
Classified as injury55%52.1%36.2%
Classified as malfunction43.2%43.5%62.3%
Filed by the manufacturer100%98.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code NVZ

BrandReportsLatest 12 monthsClassified as death
Adapta4,8932797.4%
Advisa MRI SureScan3,5892721.9%
Reply2,81491.5%
Insignia3,79201.3%
Altrua4,12202.4%
Carelink15,005180%
Sensia IPG1,391732.7%
Dextrus 41365,69800.8%
MyCareLink Patient Monitor893470.1%
Pulse Generator Permanent Implantable852241.1%
Fortify Vr U1 6 Sj4 Us1,56481.2%
Ellipse VR1,507453.7%
Symphony1,1631331.6%
Fortify Assura VR ICD, US4,8882132.3%
Consulta Crt-P68054.7%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Azure reports

How many FDA reports name Azure?

919 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

injury (55%), malfunction (43.2%) and death (1.8%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

incorrect measurement (13.1%), mechanical problem (11.1%), pacing problem (9.6%), unable to obtain readings (8.4%) and over-sensing (2.5%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Azure was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.